Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Kidney
100%
Metabolic Syndrome
98%
Renal Disease
84%
Renal Function
63%
Cardiovascular Disease
55%
High Dose
53%
Independent Risk Factors
49%
Anabolic Steroids
49%
Hypertensive Rats
49%
Kefir
49%
Liraglutide
49%
Chronic Intermittent Hypoxia
49%
Undergraduate Medical Education
49%
Spontaneously Hypertensive Rats
49%
Pharmacokinetics
49%
High Fructose
49%
Ovariectomized
49%
Multidisciplinary Approach
49%
Pharmacologist
43%
Fructose
42%
Person-to-person
24%
Cardiometabolic Disease
24%
Oxalate
24%
Metabolism
24%
Adaptation
24%
Beta-blockers
24%
Cardiovascular Dysfunction
24%
Hypoxia Condition
24%
Arterial Hypertension
24%
E. Tirucalli
24%
Euphorbia Tirucalli
24%
Normotensive Rats
24%
Oxidative Stress
23%
Creatinine Ratio
19%
Creatinine
19%
Hypertension
17%
Obstructive Sleep Apnea
16%
Ovarian Hormone Deficiency
14%
Deleterious Effects
14%
Kidney Injury
13%
Clinical Setting
12%
Blood Pressure
12%
Inactive Period
12%
Advanced Oxidation Protein Products
12%
Overall Evaluation
10%
Sodium
9%
Early Markers
9%
Glucagon-like
9%
Twice a Day
9%
Essential Hypertension
9%
Pharmacology, Toxicology and Pharmaceutical Science
Metabolic Syndrome X
98%
Kidney Disease
58%
Cardiovascular Disease
51%
Pharmacokinetic
49%
Liraglutide
49%
Androgen
49%
Kefir
49%
Chronic Intermittent Hypoxia
49%
Spontaneously Hypertensive Rat
49%
Fructose
49%
Creatinine
39%
Nephrolithiasis
24%
Kidney Stone
24%
Oxalosis 1
24%
Microflora
24%
Rat
24%
Advanced Oxidation Protein Product
24%
Kidney Injury
22%
Isotopes of Potassium
19%
Inflammation
16%
Sleep Disordered Breathing
16%
Diseases
14%
Hormone Deficiency
14%
Maturity Onset Diabetes of the Young
12%
Bioaccumulation
12%
Ascorbic Acid
12%
Glyoxylic Acid
12%
Glyoxal
12%
Aromatic Amino Acid
12%
Metabolic Disorder
12%
microRNA 132
12%
Aquaporin 1
12%
Integrin Linked Kinase
12%
Essential Hypertension
9%
Nitrite
9%
Ureaplasma
9%
Glucagon Like Peptide 1 Receptor Agonist
9%
Nitric Oxide
9%
Drug Administration
8%
Cytochrome P450 1A1
8%
Antihypertensive Agent
8%
Cerebrovascular Accident
7%
Tissue Injury
7%
Heart Infarction
7%
Proteinuria
7%
Atherosclerosis
7%
Triacylglycerol
7%
Experimental Animal
7%
Cytokine
7%
C Reactive Protein
7%
Medicine and Dentistry
Metabolic Syndrome
98%
Nephropathy
58%
Cardiovascular Disease
51%
Androgen
49%
Pharmacokinetic
49%
Spontaneously Hypertensive Rat
49%
Fructose
49%
Probiotics
49%
Cardiovascular System
28%
Chronic Intermittent Hypoxia
24%
Oxalic Acid
24%
Oxidative Stress
23%
Hormone Deficiency
14%
Kidney Function
14%
Blood Glucose
14%
Nitric Oxide
9%
Obstructive Sleep Apnea
8%
Primary Hyperoxaluria
7%
Kidney Stone
7%
Atherosclerosis
7%
Glucose Test
7%
Feeding
7%
Microalbuminuria
7%
Kidney Plasma Flow
7%
Public Health
7%
Apoplexy
7%
Tissue Injury
7%
Triacylglycerol
7%
Programmed Cell Death
7%
Cytokine
7%
Proteinuria
7%
C Reactive Protein
7%
Myocardial Infarction
7%
Hydrogen Peroxide
7%
Fenfluramine
7%
Nitrogen Oxide
7%
Glomerular Filtration Rate
7%
Glucose Metabolism
7%
Bioavailability
7%
Peroxynitrite
7%
Comorbidity
7%
Blood Pressure
7%
Postmenopause
7%
Visceral Fat
7%
Glycemic
7%
Intermittent Hypoxia
5%